Over 60 cr Covid vaccine doses administered: Govt
New Delhi: The cumulative number of COVID-19 vaccine doses administered in the country surpassed the 60-crore mark on Wednesday, Union Health minister Mansukh Mandaviya said.
"Under PM @NarendraModi ji's #SabkoVaccineMuftVaccine initiative, India crossed the 60 crore vaccination mark. Congratulations everyone!" he said in a tweet.
India took 85 days to touch the figure of 10 crore. It then took 45 days to cross the 20-crore mark and 29 more days to reach 30 crore, the minister informed.
Meanwhile, India logged 37,593 new infections, while the active cases increased marginally to 3,22,327, according to the Union Health ministry data updated on Wednesday.
The total tally of COVID-19 cases increased to 3,25,12,366 and the death toll climbed to 4,35,758 with 648 fresh fatalities, according to the data updated at 8 am.
The active cases comprise 0.99 per cent of the total infections.
The national COVID-19 recovery rate was recorded at 97.67 per cent, the ministry said.
An increase of 2,776 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
As many as 17,92,755 tests were conducted on Tuesday taking the total cumulative tests conducted so far for detection of COVID-19 in the country to 51,11,84,547.
The daily positivity rate was recorded at 2.10 per cent. It has been less than three per cent for the last 30 days.
The 648 new fatalities include 288 from Maharashtra and 173 from Kerala.
In another development, the National Technical Advisory Group on Immunisation (NTAGI) will soon hold a meeting to devise a roadmap for introducing Zydus Cadila's Covid vaccine in the inoculation drive and prioritising beneficiaries focusing on those aged 12-18 years with comorbidities.
The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20 making it the first vaccine to be administered in the age group of 12-18 years in the country.
NTAGI Chairman Dr N K Arora said it is estimated that there are around 12 crore adolescents in the age group of 12-18 years in India and less than 1 per cent of them may have comorbidities.
